Highlights of ASH North America

Registration for the 2024 Highlights of ASH in North America is now open!
Seattle, WA | January 12-13, 2024 | Fairmont Olympic Hotel
Chicago, IL | January 19-20, 2024 | Fairmont Chicago, Millennium Park Hotel
Washington, DC | January 19-20, 2024 | Omni Shoreham Hotel
New York, NY | January 26-27, 2024 | Conrad New York Hotel
Join the world's leading hematology experts at Highlights of ASH in North America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical (non-malignant) hematology. ASH is pleased to conduct this year’s series as in-person meetings; there will not be a virtual meeting platform.
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through the meeting content, you will be able to:
- Recap stand-out abstracts from the most recent ASH annual meeting
- Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field
- Participate in interactive panel discussions and attend small group lunch sessions with the experts
- Improve therapeutic and overall practice methods
- Discover new treatments for patients
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Schedule
The program schedule below is identical for all 2024 Highlights of ASH in North America locations.
11:00 a.m. | Registration and Exhibits Open Lunch (provided) |
|
11:45 p.m. | Welcome and Introductions | |
12:00 p.m. | Clonal Hematopoiesis and Myelodysplastic Syndromes | |
Yazan Madanat, MD |
Seattle, WA, and New York, NY | |
Diego Adrianzen Herrera, MD |
Chicago, IL | |
Amy E. DeZern, MD, MHS |
Washington, D.C. | |
12:45 p.m. | Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia | |
Anthony M Hunter, MD |
Seattle, WA, and Washington, D.C. | |
Srinivas Tantravahi, MD |
Chicago, IL | |
Natasha Szuber, MD, MSc Université de Montréal
|
New York, NY | |
1:30 p.m. | Chronic Lymphocytic Leukemia | |
Brian Hill, MD Cleveland Clinic
|
Seattle, WA | |
Jacqueline Barrientos, MD, MS Mount Sinai Medical Center |
Chicago, IL, and New York, NY | |
Adam Kittai, MD |
Washington, D.C. | |
2:15 p.m. | Panel Discussion | |
2:45 p.m. | Coffee Break and Exhibits Open | |
3:00 p.m. | Hemoglobinopathies | |
Kevin Kuo, MD, MSc, FRCPC University Health Network
|
Seattle, WA, and Chicago, IL | |
Seethal A. Jacob, MD, MS, FAAP Indiana University |
Washington, D.C., and New York, NY | |
3:45 p.m. | Inherited Bleeding Disorders | |
Angela Weyand, MD University of Michigan |
Seattle, WA | |
Kristen Sanfilippo, MD Washington University in St. Louis
|
Chicago, IL, and New York, NY | |
Tyler Buckner, MD, MSc University of Colorado Denver |
Washington, D.C. | |
4:30 p.m. | Diagnosis, Management, and Treatment of VTE (Venous Thromboembolism) | |
Neil Zakai, MD University of Vermont |
Seattle, WA |
|
Karlyn Martin, MD |
Chicago, IL | |
Jean Connors, MD Brigham and Women's Hospital/Harvard Medical School |
New York, NY | |
Radhika Gangaraju MD |
Washington, D.C. | |
5:15 p.m. | Panel Discussion | |
5:45 p.m. | Program concludes for the day |
|
5:45 p.m. | Satellite Symposia: "Reviving the BTK Target in MCL: Recalibrating the Treatment Sequence With Non-Covalent BTK Inhibitors in R/R Disease State Room, Chicago, IL |
7:00 a.m. | Registration and Exhibits Open Breakfast (provided) |
|
7:45 a.m. | Welcome, Introductions, and Announcements | |
8:00 a.m. |
Transfusion Medicine: Blood Banking and Pheresis |
|
Nadine Shehata, MD, MSc, FRCPC |
Seattle, WA, and Washington, D.C. | |
Stella Chou, MD |
Chicago, IL | |
Patricia A. Shi, MD |
New York, NY | |
8:45 a.m. |
Autoimmunity and Complement Disorders |
|
Yazan Abou-Ismail, MD |
Seattle, WA, and New York, NY | |
Shruti Chaturvedi, MBBS |
Chicago, IL | |
Allyson Pishko, MD |
Washington, D.C. | |
9:30 a.m. |
Nosocomial Hematological Complications |
|
Lana Castellucci, MD, MSc |
Seattle, WA, | |
Donald M. Arnold, MD |
Chicago, IL | |
Ang Li, MD, MS |
Washington, D.C. | |
Adam Cuker, MD |
New York, NY | |
10:15 a.m. | Panel Discussion | |
10:45 a.m. | Coffee Break and Exhibits Open | |
11:00 a.m. |
Myeloma & Plasma Cell Dyscrasia |
|
Rajshekhar Chakraborty, MD |
Seattle, WA | |
Surbhi Sidana, MD |
Chicago, IL | |
Jonathan L. Kaufman, MD |
Washington, D.C., and New York, NY | |
11:45 a.m. |
Lymphoma |
|
Elizabeth Lihua Budde, MD, PhD |
Seattle, WA, and Chicago, IL | |
Oreofe Odejide, MD, MPH |
New York, NY | |
Amitkumar Mehta, MD |
Washington, D.C. | |
12:30 p.m. | Panel Discussion | |
1:00 p.m. | Lunch with the Experts (All Speakers and Attendees) |
|
2:15 p.m. |
Hematopoietic Stem Cell Transplantation |
|
Shernan Holtan, MD |
Seattle, WA | |
Betty Hamilton, MD |
Chicago, IL, and New York, NY | |
John Magenau, MD |
Washington, D.C. | |
3:00 p.m. |
Acute Lymphoblastic Leukemia |
|
John Molina, MD, MEd |
Seattle, WA | |
Anand Patel, MD |
Chicago, IL, and New York, NY | |
Ryan Cassaday, MD |
Washington, D.C. | |
3:45 p.m. |
Acute Myeloid Leukemia |
|
Pamela Egan, MD |
Seattle, WA | |
Tara Lin, MD |
New York, NY | |
Justin Watts, MD |
Chicago, IL | |
Ashwin Kishtagari, MBBS Vanderbilt University
|
Washington, D.C. | |
4:30 p.m. | Panel Discussion | |
5:00 p.m. | Closing Remarks and Adjournment |
Highlights of ASH Steering Subcommittee
- Neil Zakai, MD, MSc, Chair, University of Vermont
- Tyler Buckner, MD, MSc, University of Colorado Denver
- Jean Connors, MD, Brigham and Women’s Hospital/ Harvard Medical School
- Amy DeZern, MD, Johns Hopkins University
- Pamela Egan, MD, Rhode Island Hospital
- Betty K. Hamilton, MD, Cleveland Clinic
- Jonathan L. Kaufman, MD, Emory University
- Eric Tse, PhD, MBBS, Hong Kong University
- Alison Walker, MD, Moffitt Cancer Center
Hotel Information
ASH is pleased to offer discounted room rates at each Highlights of ASH hotel for all meeting attendees. Please be sure to note the reservation deadline date for the hotel you select.